Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring

Ningyuan Wen,Dingzhong Peng,Xianze Xiong,Geng Liu,Guilin Nie,Yaoqun Wang,Jianrong Xu,Shaofeng Wang,Sishu Yang,Yuan Tian,Bei Li,Jiong Lu,Nansheng Cheng

DOI: https://doi.org/10.1038/s41392-024-01814-3

IF: 39.3

2024-05-04

Signal Transduction and Targeted Therapy

Abstract:Cholangiocarcinoma (CCA) is a highly malignant biliary tract cancer with currently suboptimal diagnostic and prognostic approaches. We present a novel system to monitor CCA using exosomal circular RNA (circRNA) via serum and biliary liquid biopsies. A pilot cohort consisting of patients with CCA-induced biliary obstruction (CCA-BO, n = 5) and benign biliary obstruction (BBO, n = 5) was used to identify CCA-derived exosomal circRNAs through microarray analysis. This was followed by a discovery cohort ( n = 20) to further reveal a CCA-specific circRNA complex (hsa-circ-0000367, hsa-circ-0021647, and hsa-circ-0000288) in both bile and serum exosomes. In vitro and in vivo studies revealed the three circRNAs as promoters of CCA invasiveness. Diagnostic and prognostic models were established and verified by two independent cohorts (training cohort, n = 184; validation cohort, n = 105). An interpreter-free diagnostic model disclosed the diagnostic power of biliary exosomal circRNA signature (Bile-DS, AUROC = 0.947, RR = 6.05) and serum exosomal circRNA signature (Serum-DS, AUROC = 0.861, RR = 4.04) compared with conventional CA19-9 (AUROC = 0.759, RR = 2.08). A prognostic model of CCA undergoing curative-intent surgery was established by calculating early recurrence score, verified with bile samples (Bile-ERS, C-index=0.783) and serum samples (Serum-ERS, C-index = 0.782). These models, combined with other prognostic factors revealed by COX-PH model, enabled the establishment of nomograms for recurrence monitoring of CCA. Our study demonstrates that the exosomal triple-circRNA panel identified in both bile and serum samples serves as a novel diagnostic and prognostic tool for the clinical management of CCA.

biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The paper attempts to address the issues of diagnosis and prognosis monitoring of Cholangiocarcinoma (CCA). Specifically:

1. **Limitations of existing diagnostic methods**: Current diagnostic methods such as imaging techniques and tissue biopsy have low diagnostic capability for small invasive lesions, and the commonly used tumor marker CA19-9 has a high false-positive rate in patients with obstructive jaundice, limiting its diagnostic efficacy.

2. **Need for early recurrence prediction**: Although radical surgery is the main treatment for CCA, the high rate of early recurrence necessitates tools to predict which patients are most likely to benefit from surgery.

To address these issues, the research team developed a new method based on exosomal circular RNA (exosomal circRNA) detection through blood and bile samples. They identified a specific set of exosomal circRNAs (hsa-circ-0000367, hsa-circ-021647, and hsa-circ-0000288) that are significantly upregulated in CCA patients and are associated with the invasiveness and early recurrence of CCA. Based on these circRNAs, the researchers established diagnostic and prognostic models and validated their effectiveness in an independent cohort. These models have higher diagnostic and prognostic accuracy than traditional markers, providing new tools for the clinical management of CCA.